Delivery Order SPE2DB20D2104-SPE2DB25FMRJP
Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $30,038.24. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $29,588.62. This firm fixed-price delivery order, which is expected to conclude by August 15, 2025, represents a competitively awarded, non-set-aside contract with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award demonstrates the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $13,807.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical vendor. The order is scheduled for completion by September 9, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,471.83 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by June 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Otezla is a pharmaceutical treatment commonly used for psoriasis, psoriatic arthritis,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,311.62 on September 15, 2025, for Otezla 20 mg tablets (60-count supply). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Otezla is a prescription medication used primarily to treat psoriasis, psoriatic arthritis, and behçet's disease. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,976.54 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,940.38. This firm fixed-price delivery order, which is not set-aside and represents the culmination of competitive procurement, is scheduled for completion by August 7, 2025. The award supports the federal medical supply chain, with performance occurring at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) under a firm fixed-price contract with a ceiling value of $15,981.04 and an ultimate completion date of July 15, 2025. This non-set-aside delivery order represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. The place of performance is located at the contractor's corporate office in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Otezla 30 mg tablets (60-count) with a ceiling value of $48,019.25. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $16,991.63 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 15, 2025. The delivery order was issued on September 12, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...